Abstract
Occupational asthma (OA) has emerged as the commonest occupational lung disease in developed countries and the second commonest in developing countries. Nearly 9-15% of the global adult asthma is occupation associated. However, this is an underestimation as large proportion of occupational asthma remains unidentified in developing world. The economic burden of OA is enormous but the disease is potentially preventable. The western models of documenting and legislation implementation models have provided a scaffold to curb various occupation morbidities of the world. Many government and non-government bodies along pertinent political inclination have been instrumental in the risk factor identification and sensitizer dose assessment for OA in the developed countries, and also ensuring that patients are adequately treated and compensated by the employers, with execution of good ergonomic practices in work places. The characteristic of OA epidemiology in developing world is contrary to the poor diagnosis, inappropriate treatment and inadequate compensation, with lack of political will. This mandates necessity of learning from developed country occupational disease models context to understanding of OA, along with reliable and feasible diagnostics and interventions that will have the potential to minimize the health hazards from the exposures at workplace environments in developing countries.
Keywords: Occupational asthma, developing countries, work-aggravated asthma.
Current Respiratory Medicine Reviews
Title:Occupational Exposure and Occupational Asthma: Difference in Practices in Developed Countries v/s Developing Countries
Volume: 12 Issue: 1
Author(s): Bill Brashier
Affiliation:
Keywords: Occupational asthma, developing countries, work-aggravated asthma.
Abstract: Occupational asthma (OA) has emerged as the commonest occupational lung disease in developed countries and the second commonest in developing countries. Nearly 9-15% of the global adult asthma is occupation associated. However, this is an underestimation as large proportion of occupational asthma remains unidentified in developing world. The economic burden of OA is enormous but the disease is potentially preventable. The western models of documenting and legislation implementation models have provided a scaffold to curb various occupation morbidities of the world. Many government and non-government bodies along pertinent political inclination have been instrumental in the risk factor identification and sensitizer dose assessment for OA in the developed countries, and also ensuring that patients are adequately treated and compensated by the employers, with execution of good ergonomic practices in work places. The characteristic of OA epidemiology in developing world is contrary to the poor diagnosis, inappropriate treatment and inadequate compensation, with lack of political will. This mandates necessity of learning from developed country occupational disease models context to understanding of OA, along with reliable and feasible diagnostics and interventions that will have the potential to minimize the health hazards from the exposures at workplace environments in developing countries.
Export Options
About this article
Cite this article as:
Brashier Bill, Occupational Exposure and Occupational Asthma: Difference in Practices in Developed Countries v/s Developing Countries, Current Respiratory Medicine Reviews 2016; 12 (1) . https://dx.doi.org/10.2174/1573398X11666151028205538
DOI https://dx.doi.org/10.2174/1573398X11666151028205538 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Chronic obstructive pulmonary disease (COPD) from childhood to adulthood: from the past to the future
Chronic obstructive pulmonary disease (COPD) is one of the three leading causes of death worldwide, with a major prevalence in low- and middle-income countries, resulting in a high social and economic cost. It is a heterogeneous respiratory disease, treatable and preventable, that causes persistent and often progressive airway obstruction in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Patent Perspective for Potential Antioxidant Compounds-Rutin and Quercetin
Recent Patents on Nanomedicine Novel Delivery Technologies: Triggering the Biopharmaceutical Potential of Boswellic Acids
The Natural Products Journal Free Radicals in Tobacco Smoke
Mini-Reviews in Organic Chemistry Granulocytes in Helminth Infection - Who is Calling the Shots?
Current Medicinal Chemistry Heme Oxygenase-1 as a Target for the Design of Gene and Pharmaceutical Therapies for Autoimmune Diseases
Current Gene Therapy Preclinical Evidence for the Pharmacological Actions of Glycyrrhizic Acid: A Comprehensive Review
Current Drug Metabolism Anti-Respiratory Syncytial Virus Mechanism of <i>Houttuynia cordata</i> Thunb Exploration based on Network Pharmacology
Combinatorial Chemistry & High Throughput Screening CD147 Interacts with NDUFS6 in Regulating Mitochondrial Complex I Activity and the Mitochondrial Apoptotic Pathway in Human Malignant Melanoma Cells
Current Molecular Medicine Recent Advances and Perceptions in Studies of Heterodimerization between G Protein-Coupled Receptors
Protein & Peptide Letters HLA-G - From Fetal Tolerance to a Regulatory Molecule in Inflammatory Diseases
Current Immunology Reviews (Discontinued) Ganoderma lucidum: A Potent Pharmacological Macrofungus
Current Pharmaceutical Biotechnology SARS-CoV-2: Molecular Biology and Therapeutic Targets
Coronaviruses Application of Human Placental Villous Tissue Explants to Study ABC Transporter Mediated Efflux of 2,4-Dinitrophenyl-S-Glutathione
Current Pharmaceutical Biotechnology An Updated Patent Therapeutic Agents Targeting MMPs
Recent Patents on Anti-Cancer Drug Discovery Protein and Antibody Engineering: Suppressing Degranulation of the Mast Cells and Type I Hypersensitivity Reaction
Current Protein & Peptide Science Modular Nanotransporters for Targeted Intracellular Delivery of Drugs: Folate Receptors as Potential Targets
Current Pharmaceutical Design MIF and the Genetic Basis of Macrophage Responsiveness
Current Immunology Reviews (Discontinued) Patent Selections
Recent Patents on Anti-Infective Drug Discovery Reflections on MicroRNAs in Chronic Pulmonary Disease: Looking into the miR-ror and Crystal Ball
Inflammation & Allergy - Drug Targets (Discontinued) A Bibliometric Analysis of Global Research on Lophomonas Spp. in Scopus (1933-2019)
Infectious Disorders - Drug Targets